Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 12 Vincristine 8 Magnetic Resonance Spectroscopy 7 Leucovorin 5 Doxorubicin 5 Cyclophosphamide 5 X-Rays 4 Radiotherapy 4 Etoposide 4 Cytarabine 4 Cisplatin 4 pegaspargase 3 Radiotherapy, Conformal 3 Radiation 3 Prednisone 3 Pemetrexed 3 Lenalidomide 3 High-Energy Shock Waves 3 Gemcitabine 3 Dexamethasone 3 Dactinomycin 3 Carboplatin 3 Biopsy 3 pembrolizumab 2 merphos 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 dehydroftorafur 2 daratumumab 2 calaspargase pegol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × vorasidenib × 30 days × Clear all

NCT06809322 2026-05-22

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡